TCT

This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures. 

RESOLVE study, RESOLVE trial, subclinical leaflet thrombosis
Feature | Heart Valve Technology

March 21, 2017 — About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood clots ...

Home March 21, 2017
Home
BVS, Absorb stent, bioresorbable scaffold, ABSORB III data, ABSORB III results
Feature | Stents Bioresorbable | Dave Fornell

March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College of Cardiology ...

Home March 21, 2017
Home
iFR, iFR vs. FFR, ACC late breaking trial, iFR-SWEDEHEART, DEFINE-FLAIR, Justin E. Davies,
Feature | FFR Technologies

March 20, 2017 — For patients experiencing angina (chest pain) or a heart attack, instantaneous wave-free ratio (iFR) ...

Home March 20, 2017
Home
News | Heart Valve Technology | Dave Fornell

March 17, 2017 - Transcatheter aortic valve replacement (TAVR) was found to be noninferior to surgical aortic valve ...

Home March 17, 2017
Home
interventional cardiology, cath lab videos
Feature | Cath Lab

Here is a compilation of some of DAIC's recent video coverage of new interventional cardiology device technologies. 

...

Home March 07, 2017
Home
Videos | Stents Bifurcation

This video, provided by Tryton, demonstrates the implantation of the Tryton Side Branch Stent. It became the first ...

Home March 06, 2017
Home
Technology | Stents Bifurcation

March 6, 2017 – The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) for the Tryton Side ...

Home March 06, 2017
Home
Technology | Stents

March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc. first-in-class Cobra PzF ...

Home March 02, 2017
Home
News | Heart Valve Technology

February 28, 2017 — A U.S. Food and Drug Administration (FDA) panel has recommended market clearance for the Claret ...

Home February 28, 2017
Home
News | Radial Access

February 22, 2017 — If hospitals can perform more transradial, same-day percutaneous coronary intervention (PCI) ...

Home February 22, 2017
Home
News | Inventory Management

February 15, 2017 — Better hospital supply chain management leads to better quality of care and supports patient safety ...

Home February 15, 2017
Home
heart team, hybird OR, structural heart team
Feature | Hybrid OR | Dave Fornell

In the current era of healthcare reform and the push toward evidence-based medicine to both lower costs and improve ...

Home February 15, 2017
Home
Blog | Stents

Stents were the key focus of interventional cardiology for more than 20 years, but the focus has changed in recent years ...

Home February 13, 2017
Home
 Intra-atrial shunt device (IASD) to lower left atrial pressure by creating a small left atrial to right atrial shunt.  Abraham said these devices are in early stage development with small studies to show proof of concept and demonstrate safety.
Feature | Heart Failure | Dave Fornell

In the past few years there have been a number of device therapies developed to treat heart failure (HF). This is partly ...

Home February 10, 2017
Home
Blog

DAIC has worked hard to bring useful technology news and resources to our readers. While we conduct reader surveys and ...

Home January 30, 2017
Home
Subscribe Now